Detalhe da pesquisa
1.
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Eur J Haematol
; 112(2): 301-309, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830403
2.
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes.
Eur J Haematol
; 2024 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38880946
3.
A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study.
Clin Infect Dis
; 77(5): 752-760, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157867
4.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697469
5.
Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE.
Br J Haematol
; 202(5): 942-952, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246588
6.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood
; 138(21): 2042-2050, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407543
7.
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Ann Hematol
; 102(4): 917-926, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820907
8.
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Eur J Haematol
; 111(4): 553-561, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461810
9.
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 111(5): 687-696, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491877
10.
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Clin Chem Lab Med
; 61(6): 1005-1014, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655501
11.
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
Support Care Cancer
; 31(10): 564, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676349
12.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 196(1): 136-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496035
13.
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Eur J Haematol
; 108(1): 61-72, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606661
14.
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Eur J Haematol
; 108(4): 288-297, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34905239
15.
Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes.
Eur J Haematol
; 108(4): 278-287, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897809
16.
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Br J Haematol
; 193(4): 779-791, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876423
17.
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
Ann Hematol
; 100(3): 789-798, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415423
18.
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol
; 100(5): 1311-1319, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33710366
19.
Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation.
Eur J Haematol
; 106(2): 241-249, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128242
20.
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Eur J Haematol
; 106(4): 508-519, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421199